Evaluation of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with cirrhosis
Javier Ariza, Francisco Gudiol, Carlos Dolz, Javier Xiol, Josefina Liñares, Jorge Bosch, Roman Pallares – 1 September 1986 – To determine the efficacy of aztreonam in the treatment of spontaneous bacterial peritonitis in patients with hepatic cirrhosis, 14 patients (7 males, 7 females) with 16 Gram‐negative infective episodes (12 Escherichia coli and 4 Klebsiella pneumoniae) were treated with aztreonam infusions at doses of 1 gm per 8 hr for a planned 14‐day period. Ages ranged from 40 to 75 years with a mean of 57 ± 10 years.